Correlation Between Greenwich Lifesciences and Transcode Therapeutics
Can any of the company-specific risk be diversified away by investing in both Greenwich Lifesciences and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Greenwich Lifesciences and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Greenwich Lifesciences and Transcode Therapeutics, you can compare the effects of market volatilities on Greenwich Lifesciences and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Greenwich Lifesciences with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Greenwich Lifesciences and Transcode Therapeutics.
Diversification Opportunities for Greenwich Lifesciences and Transcode Therapeutics
-0.16 | Correlation Coefficient |
Good diversification
The 3 months correlation between Greenwich and Transcode is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Greenwich Lifesciences and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and Greenwich Lifesciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Greenwich Lifesciences are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of Greenwich Lifesciences i.e., Greenwich Lifesciences and Transcode Therapeutics go up and down completely randomly.
Pair Corralation between Greenwich Lifesciences and Transcode Therapeutics
Given the investment horizon of 90 days Greenwich Lifesciences is expected to generate 0.24 times more return on investment than Transcode Therapeutics. However, Greenwich Lifesciences is 4.25 times less risky than Transcode Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Transcode Therapeutics is currently generating about -0.01 per unit of risk. If you would invest 1,343 in Greenwich Lifesciences on August 24, 2024 and sell it today you would earn a total of 12.00 from holding Greenwich Lifesciences or generate 0.89% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Greenwich Lifesciences vs. Transcode Therapeutics
Performance |
| Timeline |
| Greenwich Lifesciences |
| Transcode Therapeutics |
Greenwich Lifesciences and Transcode Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Greenwich Lifesciences and Transcode Therapeutics
The main advantage of trading using opposite Greenwich Lifesciences and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Greenwich Lifesciences position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.| Greenwich Lifesciences vs. Reviva Pharmaceuticals Holdings | Greenwich Lifesciences vs. Eyenovia | Greenwich Lifesciences vs. Immutep Ltd ADR | Greenwich Lifesciences vs. Anavex Life Sciences |
| Transcode Therapeutics vs. Xenetic Biosciences | Transcode Therapeutics vs. Reviva Pharmaceuticals Holdings | Transcode Therapeutics vs. Eyenovia | Transcode Therapeutics vs. Cognition Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |